Strota/ Newsroom/ 2026-09-03

MAXHEALTH (Max Healthcare Institute Ltd.): Acquisition / M&A

Strota Newsroom · session of 2026-09-03 · 03 Sep 15:29 · MAXHEALTH stock page →

Max Healthcare Institute Limited has informed the Exchange about infusion of funds in Kalinga Hospital Ltd. Historically, acquisition / m&a events have moved MAXHEALTH-type stocks in the bullish direction 48.9% of the next sessions (n=141).

Max Healthcare told the exchange on September 3 about an infusion of funds in Kalinga Hospital Ltd - an acquisition/M&A event.

For acquisition events across many past stocks, Strota's historical base rate shows a win rate of 48.9% across 141 instances with a thin average edge of 0.213% - barely better than a coin toss, a base rate for the event type, not a view on this stock.

This stock's footprint: Max Healthcare trades at a PE of 67.18 and price-to-book of 9.01, with EPS of 14.81, a market cap of 96831.0 crore and a dividend yield of 0.2%. It sits below both its 50- and 200-day averages, with RSI at 39.4, down 7.70% over the past month and 15.84% over the year. Derivatives positioning read "Long Unwinding" - open interest down 2.52% and price down 0.83%. The catalyst list also carries prior director resignations.

The data does not establish the deal will lift the price; what it shows is a hospital operator deploying capital into Kalinga, an event type that has historically been a near coin toss.

The catalyst

Max Healthcare Institute Limited has informed the Exchange about infusion of funds in Kalinga Hospital Ltd. (filing · NSE)

What the data shows after this event

Across Strota's backtest of past filings, Acquisition / M&A shows no reliable next-session edge — the move went bullish in about 48.9% of next sessions (net 0.213% after drift and cost, n=141). A base rate, not a forecast for this stock.

MAXHEALTH right now

trading +0.09% on the day; F&O shows Long Unwinding (OI -2.52% ); P/E 67.18; RSI 39.4. Full MAXHEALTH analysis →

Sources

Keep digging

How this article was made: Strota assembled the exchange data above (prices, F&O open interest, bulk/block deals, SEBI PIT filings, indicator readings and public headlines) and an AI model wrote the narrative strictly from that evidence — it is not permitted to add outside facts or numbers. Every figure comes from the underlying exchange/public data.